SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$7.63
-0.94 (-10.97%)
▼
5d:
-16.06%
30d:
-53.08%
90d:
-61.72%
WAIT
LOW Confidence
Analysis Updated: Jun 25, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SNWV is down 16.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SNWV is down 16.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.05
5.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $7.63, which is considered oversold relative to its 30-day fair value range of $10.64 to $17.09. From a valuation perspective, the stock is trading at a discount (Forward PE: 20.6) compared to its historical average (28.8). Remarkably, the market is currently pricing in an annual earnings decline of 10.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+424.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNWV is in a strong downtrend. The price is currently testing key support at $14.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.00 (+424.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.64 -
$17.09
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.0%)
- BULLISH: Trading 424.2% below Wall St target ($40.00)
- WARNING: Recommendation downgraded due to -16.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$10.64 -
$17.09
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$14.52
Resistance Level
$17.07
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.62
Wall Street Target
$40.00
(+424.2%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
37.2%
Valuation Discount vs History
-10.5% cheaper
PE vs Historical
20.6 vs 28.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.5%
(market-implied from PE analysis)
1-Year Target
$6.87
(-10%)
2-Year Target
$6.18
(-19%)
3-Year Target
$5.56
(-27%)
3-Yr Target (if PE normalizes)
(PE: 21→29)
$7.77
(+2%)
📈
Valuation based on Current Earnings
Trailing PE: 8.93 | Current EPS (TTM): $0.96
Bull Case
$4.71
(-38%)
Analyst growth -50.0%, PE expands to 9.8
Base Case
$4.29
(-44%)
Market implied -50.0%, PE stable at 8.9
Bear Case
$5.83
(-24%)
Severe decline -20.0%, PE contracts to 7.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.6 to 28.8
Stabilization Target:
$10.66
(+39.7%)
PE Expansion Potential:
+39.7%
Share & Embed Analysis
Last updated: June 25, 2026 7:56 PM ET
Data refreshes hourly during market hours. Next update: 8:56 PM
Data refreshes hourly during market hours. Next update: 8:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 55 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 64 BUY |
